Skip to main content

Advertisement

Log in

Label free quantitative proteomic profiling of serum samples of intellectually disabled young patients revealed dysregulation of complement coagulation and cholesterol cascade systems

  • Original Article
  • Published:
Metabolic Brain Disease Aims and scope Submit manuscript

Abstract

Intellectual disability is a heterogeneous disorder, diagnosed using intelligence quotient (IQ) score criteria. Currently, no specific clinical test is available to diagnose the disease and its subgroups due to inadequate understanding of the pathophysiology. Therefore, current study was designed to explore the molecular mechanisms involved in disease perturbation, and to identify potential biomarkers for disease diagnosis and prognosis. A total of 250 participants were enrolled in this study, including 200 intellectually disabled (ID) subjects from the subgroups (mild, moderate, and severe) with age and gender matched healthy controls (n = 50). Initially, IQ testing score and biochemical profile of each subject was generated, followed by label-free quantitative proteomics of subgroups of IQ and healthy control group through nano-LC/MS- mass spectrometry. A total of 310 proteins were identified, among them198 proteins were common among all groups. Statistical analysis (ANOVA) of the subgroups of ID showed 142 differentially expressed proteins, in comparison to healthy control group. From these, 120 proteins were found to be common among all subgroups. The remaining 22 proteins were categorized as exclusive proteins found only in disease subgroups. Furthermore, the hierarchical cluster analysis (HCL) of common significant proteins was also performed, followed by PANTHER protein classification and GO functional enrichment analysis. Results provides that the datasets of differentially expressed proteins, belong to the categories of immune / defense proteins, transfer carrier proteins, apolipoproteins, complement proteins, protease inhibitors, hemoglobin proteins etc., they are known to involvein immune system, and complement and coagulation pathway cascade and cholesterol metabolism pathway. Exclusively expressed 22 proteins were found to be disease stage specific and strong PPI network specifically those that have significant role in platelets activation and degranulation, such as Filamin A (FLNA). Furthermore, to validate the mass spectrometric findings, four highly significant proteins (APOA4, SAP, FLNA, and SERPING) were quantified by ELISA in all the study subjects. AUROC analysis showed a significant association of APOA4 (0.830), FLNA (0.958), SAP (0.754) and SERPING (0.600) with the disease. Apolipoprotein A4 (APOA4) has a significant role in cholesterol transport, and in modulation of glucose and lipid metabolism in the CNS. Similarly, FLNA has a crucial role in the nervous system, especially in the functioning of synaptic network. Therefore, both APOA4, and FLNA proteins represent good potential for candidate biomarkers for the diagnosis and prognosis of the intellectual disability. Overall, serum proteome of ID patients provides valuable information of proteins/pathways that are altered during ID progression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

Data availability

The complete proteomics dataset used and/or analyzed in the present study can be accessed in the electronic supplementary file ESI. Individual healthy/patient’s samples data will be provided on request from the corresponding author.

Abbreviations

AUC:

Area under the curve

DSM:

Statistical manual of mental disorders

FDR:

False discovery rate

GO:

Gene ontology

HCL:

Hierarchical cluster analysis

ID:

Intellectual disability

IQ:

Intelligence quotient

LC/MS:

Liquid chromatography–mass spectrometry

NS-ID:

Non-syndromic intellectual disability

PANTHER:

Protein analysis through evolutionary relationships

ROC:

Receiver operating characteristics

SECs:

Special education centers

S-ID:

Syndromic intellectual disability

STRING:

Search tool for the retrieval of interacting genes/proteins

TFA:

Trifluoroacetic acid

References

  • Atallah I, Quinodoz M, Campos-Xavier B, Peter VG, Fouriki A, Bonvin C, Bottani A, Kumps C, Angelini F, Bellutti Enders F (2021) Immune deficiency, autoimmune disease and intellectual disability: a pleiotropic disorder caused by biallelic variants in the TPP2 gene. Clin Genet 99(6):780–788

    Article  CAS  PubMed  Google Scholar 

  • Aureli A, Sebastiani P, Del Beato T, Marimpietri AE, Graziani A, Sechi E, Di Loreto S (2014) Involvement of IL-6 and IL-1 receptor antagonist on intellectual disability. Immunol Lett 162(1):124–131

    Article  CAS  PubMed  Google Scholar 

  • Bahk J, Kang H-Y, Khang Y-H (2019) The life expectancy gap between registered disabled and non-disabled people in Korea from 2004 to 2017. Int J Environ Res Public Health 16(14):2593

    Article  PubMed  PubMed Central  Google Scholar 

  • Benmakhlouf Y, Zian Z, Nourouti NG, Barakat A, Mechita MB (2021) Potential cytokine biomarkers in intellectual disability. Endocr Metab Immune Disord Drug Targets 21(4):569–576. https://doi.org/10.2174/1871530320666200628024944

    Article  CAS  PubMed  Google Scholar 

  • Berkowitz S, Chapman J, Dori A, Gofrit SG, Maggio N, Shavit-Stein E (2021) Complement and coagulation system crosstalk in synaptic and neural conduction in the central and peripheral nervous systems. Biomedicines 9(12):1950

  • Boat TF, Wu JT (eds) (2015) Mental disorders and disabilities among low-income children. https://doi.org/10.17226/21780

  • Boiko AS, Mednova IA, Kornetova EG, Semke AV, Bokhan NA, Loonen AJM, Ivanova SA (2019) Apolipoprotein serum levels related to metabolic syndrome in patients with schizophrenia. Heliyon, 5(7):e02033

    Article  PubMed  PubMed Central  Google Scholar 

  • Carmeli E, Imam B, Bachar A, Merrick J (2012) Inflammation and oxidative stress as biomarkers of premature aging in persons with intellectual disability. Res Dev Disabil 33(2):369–375

    Article  PubMed  Google Scholar 

  • Corraliza-Gomez M, Sanchez D, Ganfornina MD (2019) Lipid-binding proteins in brain health and disease. Front Neurol 10:1152

    Article  PubMed  PubMed Central  Google Scholar 

  • Dalakas MC, Alexopoulos H, Spaeth PJ (2020) Complement in neurological disorders and emerging complement-targeted therapeutics. Nat Reviews Neurol 16(11):601–617

    Article  Google Scholar 

  • De Ligt J, Willemsen MH, Van Bon BWM, Kleefstra T, Yntema HG, Kroes T, Vulto-van Silfhout AT, Koolen DA, De Vries P, Gilissen C (2012) Diagnostic exome sequencing in persons with severe intellectual disability. N Engl J Med 367(20):1921–1929

    Article  PubMed  Google Scholar 

  • De Winter CF, Bastiaanse LP, Hilgenkamp TIM, Evenhuis HM, Echteld MA (2012) Cardiovascular risk factors (diabetes, hypertension, hypercholesterolemia and metabolic syndrome) in older people with intellectual disability: results of the HA-ID study. Res Dev Disabil 33(6):1722–1731

    Article  PubMed  Google Scholar 

  • Esposito CM, Buoli M, Ciappolino V, Agostoni C, Brambilla P (2021) The role of cholesterol and fatty acids in the etiology and diagnosis of autism spectrum disorders. Int J Mol Sci 22(7):3550

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Fan Y, Gao J, Li Y, Chen X, Zhang T, You W, Xue Y, Shen C (2021) The variants at APOA1 and APOA4 contribute to the susceptibility of Schizophrenia with inhibiting mRNA expression in Peripheral Blood leukocytes. Front Mol Biosci 8:785445

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Glinton KE, Elsea SH (2019) Untargeted metabolomics for autism spectrum disorders: current status and future directions. Front Psychiatry 10:647

    Article  PubMed  PubMed Central  Google Scholar 

  • Hu H, Kahrizi K, Musante L, Fattahi Z, Herwig R, Hosseini M, Oppitz C, Abedini SS, Suckow V, Larti F (2019) Genetics of intellectual disability in consanguineous families. Mol Psychiatry 24(7):1027–1039

    Article  CAS  PubMed  Google Scholar 

  • Huang J, Zhu T, Qu Y, Mu D (2016) Prenatal, perinatal and neonatal risk factors for intellectual disability: a systemic review and meta-analysis. PLoS ONE, 11(4), e0153655

    Article  Google Scholar 

  • Hussain H, Wasim M, Khan HN, Ayesha H, Awan FR (2022) Molecular analyses of Phenylketonuria in the intellectually disabled children from Faisalabad, Punjab, Pakistan. Pakistan J Neurol Sci (PJNS) 17(2):21–26

    Google Scholar 

  • Iwase S, Bérubé NG, Zhou Z, Kasri NN, Battaglioli E, Scandaglia M, Barco A (2017) Epigenetic etiology of intellectual disability. J Neurosci 37(45):10773–10782

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kaufman L, Ayub M, Vincent JB (2010) The genetic basis of non-syndromic intellectual disability: a review. J Neurodevelopmental Disorders 2(4):182–209

    Article  Google Scholar 

  • Kim Y-S, Kim J-H, Kwon S, Ho S (2022) Mortality rate and cause among people with intellectual disabilities in South Korea: a nationwide representative cross-sectional study from 2015 to 2019. PLOS Global Public Health, 2(7), e0000744

    Article  Google Scholar 

  • Landes SD, Stevens JD, Turk MA (2021) Cause of death in adults with intellectual disability in the United States. J Intellect Disabil Res 65(1):47–59

    Article  CAS  PubMed  Google Scholar 

  • Lee JD, Coulthard LG, Woodruff TM (2019) Complement dysregulation in the central nervous system during development and disease. Semin Immunol 45:101340

    Article  CAS  PubMed  Google Scholar 

  • Lee J, Mun S, Park A, Kim D, Lee Y-J, Kim H-J, Choi H, Shin M, Lee SJ, Kim JG (2020) Proteomics reveals plasma biomarkers for ischemic stroke related to the coagulation cascade. J Mol Neurosci 70:1321–1331

    Article  CAS  PubMed  Google Scholar 

  • Li H, Xie X, Bai G, Qiang D, Zhang L, Liu H, He Y, Tang Y, Li L (2023) Vitamin D deficiency leads to the abnormal activation of the complement system. Immunol Res 71(1):29–38

    Article  CAS  PubMed  Google Scholar 

  • Liu Z, Wang J, Xu Q, Hong Q, Zhu J, Chi X (2021) Research progress in vitamin A and autism spectrum disorder. Behav Neurol 2021:5417497

    Article  PubMed  PubMed Central  Google Scholar 

  • Loth E, Charman T, Mason L, Tillmann J, Jones EJH, Wooldridge C, Ahmad J, Auyeung B, Brogna C, Ambrosino S (2017) The EU-AIMS Longitudinal European Autism Project (LEAP): design and methodologies to identify and validate stratification biomarkers for autism spectrum disorders. Mol Autism 8(1):1–19

    Article  Google Scholar 

  • Manti S, Cutrupi MC, Cuppari C, Ferro E, Dipasquale V, Di Rosa G, Chimenz R, La Rosa MA, Valenti A, Salpietro V (2018) Inflammatory biomarkers and intellectual disability in patients with Down syndrome. J Intellect Disabil Res 62(5):382–390

    Article  CAS  PubMed  Google Scholar 

  • Maulik PK, Mascarenhas MN, Mathers CD, Dua T, Saxena S (2011) Prevalence of intellectual disability: a meta-analysis of population-based studies. Res Dev Disabil 32(2):419–436

    Article  PubMed  Google Scholar 

  • Mirza MR, Sultan R, Choudhary MI, Tahir M, Larsen MR, Tariq S, Rahman SU (2022) Label-free quantitation of the changes in salivary proteome associated with the chronic consumption of the betel nut (Areca catechu). Mol Omics 18(2):123–132

    Article  CAS  PubMed  Google Scholar 

  • Murtaza N, Uy J, Singh KK (2020) Emerging proteomic approaches to identify the underlying pathophysiology of neurodevelopmental and neurodegenerative disorders. Mol Autism 11(1):1–15

    Article  Google Scholar 

  • Naji MT, Sami OM, Shams HA, Abdul-Hadi MH, Al-Kuraishy HM, Al-Gareeb AI, Al-Harchan NA-A (2020) The associations between retinol binding protein-4 and cardiometabolic profile: intertwined-intricate relationship. Biomedical Biotechnol Res J (BBRJ) 4(2):95–107

    Article  Google Scholar 

  • Nemerimana M, Chege MN, Odhiambo EA (2018) Risk factors associated with severity of nongenetic intellectual disability (mental retardation) among children aged 2–18 years attending Kenyatta National Hospital. Neurol Res Int 2018

  • Onore C, Careaga M, Ashwood P (2012) The role of immune dysfunction in the pathophysiology of autism. Brain Behav Immun 26(3):383–392

    Article  CAS  PubMed  Google Scholar 

  • Pangrazzi L, Balasco L, Bozzi Y (2020) Oxidative stress and immune system dysfunction in autism spectrum disorders. Int J Mol Sci 21(9):3293

    Article  PubMed  PubMed Central  Google Scholar 

  • Parsamanesh N, Miri-Moghaddam E (2018) Novel insight into intellectual disability; a review article. Gene Cell Tissue 5(4)

  • Patel DR, Apple R, Kanungo S, Akkal A (2018) Narrative review of intellectual disability: definitions, evaluation and principles of treatment. Pediatr Med 1:11

    Article  Google Scholar 

  • Patel DR, Cabral MD, Ho A, Merrick J (2020) A clinical primer on intellectual disability. Translational Pediatr 9(Suppl 1):S23

    Article  Google Scholar 

  • Rau JC, Beaulieu LM, Huntington JA, CHURCH FC (2007) Serpins in thrombosis, hemostasis and fibrinolysis. J Thromb Haemost 5:102–115

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Robertson J, Heslop P, Lauer E, Taggart L, Hatton C (2021) Gender and the premature deaths of people with intellectual disabilities: an international expert consultation. J Policy Pract Intellect Disabil 18(2):89–103

    Article  Google Scholar 

  • Sánchez-Navarro A, González-Soria I, Caldiño-Bohn R, Bobadilla NA (2021) An integrative view of serpins in health and disease: the contribution of SerpinA3. Am J Physiology-Cell Physiol 320(1):C106–C118

    Google Scholar 

  • Schoufour JD, Echteld MA, Boonstra A, Groothuismink ZMA, Evenhuis HM (2016) Biochemical measures and frailty in people with intellectual disabilities. Age Ageing 45(1):142–148

    Article  PubMed  Google Scholar 

  • Sengupta A, Das U, Manna K, Biswas S, Datta S, Khan A, Bhattacharya T, Saha S, Mitra T, Mukherjee S (2019) An association study of severity of intellectual disability with peripheral biomarkers of disabled children in a rehabilitation home, Kolkata, India. Sci Rep 9(1):13652

    Article  PubMed  PubMed Central  Google Scholar 

  • Toutonji A, Mandava M, Guglietta S, Tomlinson S (2021) Chronic complement dysregulation drives neuroinflammation after traumatic brain injury: a transcriptomic study. Acta Neuropathol Commun 9(1):1–18

    Article  Google Scholar 

  • Üstkoyuncu PS, Güven AS, Dündar MA, Mutlu FT, Torun YA (2020) Can hematological parameters indicate possible inflammatory mechanisms in children with intellectual disability? Erciyes Med Journal/Erciyes Tip Dergisi 42(3)

  • van der Velpen V, Teav T, Gallart-Ayala H, Mehl F, Konz I, Clark C, Oikonomidi A, Peyratout G, Henry H, Delorenzi M (2019) Systemic and central nervous system metabolic alterations in Alzheimer’s disease. Alzheimer’s Res Therapy 11:1–12

    Google Scholar 

  • Vancampfort D, Schuch F, Van Damme T, Firth J, Suetani S, Stubbs B, Van Biesen D (2020) Metabolic syndrome and its components in people with intellectual disability: a meta-analysis. J Intellect Disabil Res 64(10):804–815

    Article  CAS  PubMed  Google Scholar 

  • Wang M, Cui C, Jin F (2022) Research progress on the correlation between vitamin D and neurological disorders. Turkish Neurosurg 32:347–356

    Google Scholar 

  • Warwick CA, Keyes AL, Woodruff TM, Usachev YM (2021) The complement cascade in the regulation of neuroinflammation, nociceptive sensitization, and pain. J Biol Chem 297(3)

  • Wasim M, Khan HN, Ayesha H, Goorden SMI, Vaz FM, Van Karnebeek CDM, Awan FR (2019) Biochemical screening of intellectually disabled patients: a stepping stone to initiate a newborn screening program in Pakistan. Front Neurol 10:762

    Article  PubMed  PubMed Central  Google Scholar 

  • Wasim M, Khan HN, Ayesha H, Iqbal M, Tawab A, Irfan M, Kanhai W, Goorden SMI, Stroomer L, Salomons G (2022) Identification of three novel pathogenic mutations in cystathionine beta-synthase gene of Pakistani intellectually disabled patients. J Pediatr Endocrinol Metab 35(3):325–332

    PubMed  Google Scholar 

  • Zafar M, Mirza MR, Awan FR, Tahir M, Sultan R, Hussain M, Bilal A, Abbas S, Larsen MR, Choudhary MI (2021) Effect of APOB polymorphism rs562338 (G/A) on serum proteome of coronary artery disease patients: a proteogenomic approach. Sci Rep 11(1):22766

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zengeler KE, Lukens JR (2021) Innate immunity at the crossroads of healthy brain maturation and neurodevelopmental disorders. Nat Rev Immunol 21(7):454–468

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ziliotto N, Bernardi F, Jakimovski D, Zivadinov R (2019) Coagulation pathways in neurological diseases: multiple sclerosis. Front Neurol 10:409

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The Villum Center for Bioanalytical Sciences at University of Southern Denmark (SDU), Odense, Denmark, is acknowledged for access to advanced LC-MSMS instrumentation. National Institute for Biotechnology and Genetic Engineering (NIBGE), and Faisalabad Medical University for contributions in the study cohort recruitment, sampling and analysis.

Funding

All the experimental work was performed by a recurring grant of Dr. Panjwani Center for Molecular Medicine and Drug Research (ICCBS). There was no funding available to support the publication of this research work.

Author information

Authors and Affiliations

Authors

Contributions

This study was initially conceived and designed by M.R.M., F.R.A., and M.I.C., Sample collection, study approvals and biochemical assays were taken by F.R.A, M.W., H.A., H.N.K., and M.Z., Sample preparation for mass spectrometry and ELISA assays were performed by S.V., and M.R.M. Mass spectrometric analysis was performed by S.V., M.R.M., A.N., and M.R.L. Data analysis and interpretation by S.V., M.R.M., M.Z., and F.R.A. Manuscript first draft was prepared by S.V. which was further reviewed and edited by all the authors of the manuscript.

Corresponding authors

Correspondence to Munazza Raza Mirza or Fazli Rabbi Awan.

Ethics declarations

Ethics approval and consent to participate

This study was approved by Ethical Review Committee of National Institute for Biotechnology and Genetic Engineering (NIBGE), Faisalabad, and Independent Ethics Committee (Protocol Ref.: ICCBS/IEC-093-HB/HUS-2023/Protocol/2.0), International Centre for Chemical and Biological Sciences (ICCBS), University of Karachi, Pakistan. Duly signed informed consents were obtained from parents/guardians of all study participants prior to sample (blood and urine) collection. The study was carried out according to the guidelines of the 1964 Declaration of Helsinki.

Consent for publication

Not applicable.

Competing interests

All the authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Material 1

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vankwani, S., Mirza, M.R., Awan, F.R. et al. Label free quantitative proteomic profiling of serum samples of intellectually disabled young patients revealed dysregulation of complement coagulation and cholesterol cascade systems. Metab Brain Dis (2024). https://doi.org/10.1007/s11011-024-01351-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s11011-024-01351-6

Keywords

Navigation